Estrogen receptor—positive breast cancer survival prediction and analysis of resistance–related genes introduction
Background In recent years, ER+ and HER2- breast cancer of adjuvant therapy has made great progress, including chemotherapy and endocrine therapy. We found that the responsiveness of breast cancer treatment was related to the prognosis of patients. However, reliable prognostic signatures based on ER...
Main Authors: | Chen Shuai, Fengyan Yuan, Yu Liu, Chengchen Wang, Jiansong Wang, Hongye He |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2021-10-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/12202.pdf |
Similar Items
-
Correlation of HER-2/neu Status with Estrogen (ER) & Progesterone (PR) Receptor in Breast Malignancies
by: Asma Rasheed, et al.
Published: (2020-12-01) -
Classification of Estrogen Receptor-Positive Breast Cancer Based on Immunogenomic Profiling and Validation at Single-Cell Resolution
by: Xianxiong Ma, et al.
Published: (2021-09-01) -
Activity of Estrogen Receptor β Agonists in Therapy-Resistant Estrogen Receptor-Positive Breast Cancer
by: Jharna Datta, et al.
Published: (2022-04-01) -
The Correlation between Traditional Ultrasound Features and the Expression of Estrogen Receptor, Progesterone Receptor, Human Epidermal Growth Factor Receptor-2, and Ki-67 in Breast Carcinoma
by: Ping Wang, MM, Junfan Li, Wensheng Yue, MM, Wenyan Li, MM, Yuqun Luo, MM
Published: (2018-12-01) -
Integrated multi‐omics profiling of high‐grade estrogen receptor‐positive, HER2‐negative breast cancer
by: Kang Wang, et al.
Published: (2022-06-01)